Biotech

All Articles

Analysts dig into Avidity's DMD succeed, exposing nuances in information

.Avidity Biosciences impressed entrepreneurs along with phase 1/2 data in Duchenne muscular dystroph...

Actinogen's cortisol blocker fails stage 2 depression research

.Actinogen Medical's cortisol blocker has actually overlooked the primary endpoint of a stage 2 rese...

Bivictrix decides going exclusive only technique to take ADC into center

.Antibody-drug conjugates (ADCs) have been at the center of several a billion-dollar biobuck licensi...

TPG bests up funds to $580M for financial investments around lifestyle sciences

.Property supervisor TPG, which has supported biotechs like Sionna Therapeutics as well as Santa Cla...

Merck stops phase 3 TIGIT test in lung cancer cells for futility

.Merck &amp Co.'s TIGIT system has actually gone through another setback. Months after shuttering a ...

After a tough year, Exscientia folds right into Recursion

.After a year defined through pipeline cuts, the variation of its CEO and also layoffs, Exscientia w...

Cullinan, after $25M offer, hands back bispecific to Port

.Cullinan Rehab was actually wowed good enough with Port BioMed's bispecific invulnerable reactor th...

A nearer look at Brutal Biotech's Tough 15

.In this week's episode of "The Top Pipe," we are actually diving into Strong Biotech's annual Tough...

Lilly faces phase 2 failure of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's event commemorating the commendation...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings a...